financetom
Business
financetom
/
Business
/
GameStop Slides Another 6% as Investors Sell the Bitcoin Buy News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GameStop Slides Another 6% as Investors Sell the Bitcoin Buy News
May 29, 2025 1:24 PM

GameStop ( GME ) shares dropped nearly another 6% on Thursday as investors continued to sell the news of the company's disclosure of its initial bitcoin acquisitons.

The company on Wednesday morning said it had acquired 4,710 bitcoin — a long-awaited move tied to its crypto treasury strategy revealed in March. At that time, the company initiated a $1.3 billion capital raise to help fund BTC purchases.

The stock plunged shortly after alongside a steep drop in broader markets on the Trump Liberation Day tariff announcements. Shares, though, bottomed along with markets mid-month and rose more than 60% in the weeks leading up to the Wednesday announcement.

The decline since — now nearing 20% — could be little more than investors selling the news after the big run higher or could be investor exhaustion with corporate bitcoin treasury strategies, which seemingly have been coming at the rate of one or more per day for several weeks.

In addition, GameStop's ( GME ) acquisition of "just" roughly $500 million of bitcoin (the dates and prices of the buys weren't disclosed) could be a disappointment given the company's $1.3 billion capital raise, not to mention several billion dollars in free cash that was already on the balance sheet. With a market cap of $14 billion, the company’s bitcoin purchase was relatively modest.

Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk’s full AI Policy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hanesbrands Seen Facing Stock Volatility After Champion Brand Sale, UBS Says
Hanesbrands Seen Facing Stock Volatility After Champion Brand Sale, UBS Says
Jul 24, 2024
03:35 PM EDT, 07/24/2024 (MT Newswires) -- Hanesbrands' ( HBI ) 2024 guidance, excluding its Champion brand's 30% sales contribution, probably will spur stock price volatility, UBS Securities said Wednesday in a report. We anticipate Hanesbrands ( HBI ) will give new retroactive financials removing Champion's results so investors can compare current trends to prior periods on a like-for-like basis,...
Why Bausch health Shares Are Falling Today
Why Bausch health Shares Are Falling Today
Jul 24, 2024
Bausch Health Companies Inc. ( BHC ) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged Chapter 11 bankruptcy with co-op creditor. The company later issued a statement, firmly denying any discussions related to bankruptcy or insolvency proceedings. What Happened: The initial report from...
Update: Market Chatter: Lyft to Implement Safety Reforms to Settle Lawsuit Over Sexual Assault by Drivers
Update: Market Chatter: Lyft to Implement Safety Reforms to Settle Lawsuit Over Sexual Assault by Drivers
Jul 24, 2024
03:45 PM EDT, 07/24/2024 (MT Newswires) -- (Updates with additional details throughout.) Lyft ( LYFT ) has agreed to implement new safety and governance measures to resolve a shareholder lawsuit alleging insufficient action by the company's officers and directors to address incidents of sexual and physical assault by drivers, Reuters reported Wednesday, citing a court filing. The preliminary settlement, filed...
Skye Bioscience to Track Sleep Activity in Phase 2 Trial of Obesity Drug
Skye Bioscience to Track Sleep Activity in Phase 2 Trial of Obesity Drug
Jul 24, 2024
03:39 PM EDT, 07/24/2024 (MT Newswires) -- Skye Bioscience ( SKYE ) is partnering with privately held Beacon Biosignals for devices to monitor brain activity during sleep in some of the participants in an upcoming trial of prospective obesity medication, Beacon said Wednesday. Skye Bioscience ( SKYE ) said separately it will begin screening participants for a phase 2 trial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved